Connect with us

Hi, what are you looking for?

Jewish Business News


Israel tech exits at 5-year low of $1.95 billion in first half

Exits in first half 2017 reached just 20% of 2016 total ($B); Seven IPOs totaled $227 million in; 40% of Israeli companies’ acquisitions were made locally

Key facts:
• Exits in first half 2017 reached just 20% of 2016’s annual exit total ($B)
• Seven IPOs totaled $227 million in first half 2017
• 40% of Israeli companies’ acquisitions were made locally

In the first half of 2017, Israeli high-tech exits totaled $1.95 billion in 57 deals, according to the IVC-Meitar Exits Report published today.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

Exits in first half 2017 comprised 46 merger & acquisition (M&A) deals, seven initial public offerings (IPOs) and four buyouts, totaling $1.51 billion, $227 million, and $218 million, respectively. The average exit deal in the first half of 2017 reached $34 million, much lower than the annual exit average of $87 million in 2016. In fact, exits in first half 2017 were at a five-year low, both in terms of deal number and total amount in billions.

The largest deals in the first half of 2017 were the $340 million acquisition of Valtech by Edwards Lifescience (US) and $200 million acquistion of Juno LAB by Gett (Israel), followed by the $170 million acquisition of Servotronix by Midea (China). The top three deals accounted for more than $700 million, nearly 36 percent of total exit deals in this period.

IPO deals experienced a relative recovery in first half 2017, with seven IPOs grossing $227 million. Both the number of IPOs and $M amounts were higher than last year’s figures, which reached a mere $22 million in five IPO transactions.

According to Adv. Alon Sahar, from Meitar Liquornik Geva Leshem Tal, global changes, such as those related to a possible fundamental change in the US taxation regime, or regulatory changes in China related to the right of businesses to spend capital outside the country, partially explain the slowdown:

“The current report, covering the first half of 2017, alongside the second half of 2016, indicate a clear trend – a decrease in the number of merger & acquisition deals, which requires an explanation. We believe that the possible change in taxation regime in United States forces American acquirers to rethink their capital management strategies, which greatly affects modelling the deals in process. The regulatory boundaries in China suspended significant activity by Chinese acquirers, or discouraged Israeli companies from negotiating with potential Chinese acquirers.”

Sahar added: “It is important to remember that a large portion of companies which were very active in the local acquisitions arena underwent significant organizational changes related to their core activities. Naturally, changes delay decision making on M&A deals, regardless of the Israeli market. When a corporate strategy matures, corporations implement it, usually through acquisitions. Sometimes the acquired company is at the core of the strategic change. A case in point is the Mobileye acquisition by Intel, which is expected to be closed by the end of this year. Sometimes, however, acquisitions are the missing piece in the puzzle.” According to Sahar, in recent years, that same Microsoft performed a series of cyber security acquisitions locally after having frozen virtually all M&A activity in Israel, becoming an active acquirer locally.

Adv. Dan Shamgar, suggests an additional explanation for the decrease in the number of M&As: “We should take into account the noticeable growth in the volume of investments and the availability of capital for growth stages. The number of deals in which companies raise tens of millions in dollars in proceeds has never been higher. The increasing variety of investors supporting late stage companies and the capital volume which has been available to companies for growth purposes – are the largest ever.”

Shamgar mentions often-heard suggestions, according to which private company valuations are too high, which creates an unbridgeable gap between ask and bid prices. “Some claim this is the industry’s way to support more significant companies, and that the value creation will occur later. Although we took part in a number of significant M&A deal negotiations that were not carried out due to price gaps, we believe that there are more mature companies in Israel than ever. We may only hope that this fact will be translated into deals with higher prices than we have seen in the past.”
In addition, Sahar and Shamgar point out that some of the industries considered “hot” in capital raising are only making their debuts in Israel, specifically AR, VR, and robotics.
Koby Simana, CEO of IVC Research Center, believes there are two sides to this coin: “A healthy industry needs the right mix, including growth-stage technology companies – which strengthen the industry, but also the ability to realize investments and return money to investors, with exits being one option. It is possible that investment trends in growth companies created an overshooting of growth investments, resulting in investor and entrepreneur reluctans to sell companies and realize their investments at current market value, in hope of possible better returns in the future. However, I believe that the first half-year has not seen enough company acquisitions, and among the ones that were acquired, we did not see enough medium to large deals, of the type the venture capital industry is after. We hope that the industry will regain a healthier balance in the second half of 2017.”

Israeli companies continued their local shopping spree in the first half of 2017, though at lower volumes than in previous years. Two-sided Israeli M&A deals captured 40 percent of dollar volume in acquisition made by Israeli companies in 2017 so far, both in Israel and abroad. The most prominent Israeli through and through deal was with Gett acquiring Juno LAB for $200 million (the second largest deal closed in 2017 so far). A total of 15 such deals were recorded since the beginning of the year, garnering $256 million, which represents a 79 percent year-on-year decrease: in 2016, 34 deals involving Israeli companies on the both sides accounted for $1.2 billion in total. In first half 2017, Israeli companies spent $389 million on acquisitions of foreign companies, in 16 deals.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.